Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice
Open accessAbstract
There is growing evidence that neuropeptide Y (NPY) acting through Y1 and Y2 receptors has a prominent role in modulating anxiety- and depression-like behavior in rodents. However, a role of other Y-receptors like that of Y4 receptors in this process is poorly understood. We now investigated male Y2, Y4 single and Y2/Y4 double knockout mice in behavioral paradigms for changes in motor activity, anxiety and depression-like behavior. Motor activity was increased in Y2, Y4 and Y2/Y4 knockout mice under changing and stressful conditions, but not altered in a familiar environment. Y4 and Y2 knockout mice revealed an anxiolytic phenotype in the light/dark test, marble burying test and in stress-induced hyperthermia, and reduced depression-like behavior in the forced swim and tail suspension tests. In Y2/Y4 double knockout mice, the response in the light/dark test and in the forced swim test was further enhanced compared with Y4 and Y2 knockout mice, respectively. High levels of Y4 binding sites were observed in brain stem nuclei including nucleus of solitary tract and area postrema. Lower levels were found in the medial amygdala and hypothalamus. Peripheral administration of pancreatic polypeptide (PP) induced Y4 receptor-dependent c-Fos expression in brain stem, hypothalamus and amygdala. PP released peripherally from the pancreas in response to food intake, may act not only as a satiety signal but also modulate anxiety-related locomotion.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Y4 receptor, which is mainly activated by peripheral PP, modulates anxiety and fear-related disorders in rodents.
“The Y 4 receptor, which is mainly activated by peripheral PP, modulates anxiety and fear-related disorders in rodents [174,185,186].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · cited 3× · see citing works
“The elevated plus maze was performed as previously described (Pellow et al., 1985; Lister, 1987).”
MethodDepression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 3× · see citing works
“, 1985; Lister, 1987; Rodgers and Dalvi, 1997)and the light/dark box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980) and depressionlike behavior in the forced swim test (Lucki, 1997; Petit-Demouliere et al., 2005; Porsolt et al., 1977) and tail suspension test (Cryan et al.”
BackgroundMethodThe tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 4× · see citing works
“The tail suspension test was performed as described previously (Mayorga and Lucki, 2001; Steru et al., 1985).”
BackgroundMethodInfluentialThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,190 · cited 1× · see citing works
“In addition, basal and novelty-induced locomotor activity were examined by home-cage activity and in the open field test (Hall, 1934; Prut and Belzung, 2003), respectively.”
MethodThe use of a plus-maze to measure anxiety in the mouse
Lister, R. G. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,617 · cited 2× · see citing works
“The elevated plus maze was performed as previously described (Pellow et al., 1985; Lister, 1987).”
MethodCryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674 · cited 3× · see citing works
“, 2002; Lucki, 1997), including selective 5-HT reuptake inhibitors and it is independent of swimming ability or thermoregulation (Cryan and Mombereau, 2004; Cryan et al., 2005).”
BackgroundAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 3× · see citing works
“In contrast to the traditional forced swim test, the tail suspension test detects the efficacy of a broad spectrum of antidepressant treatments (Cryan et al., 2002; Lucki, 1997), including selective 5-HT reuptake inhibitors and it is independent of swimming ability or thermoregulation (Cryan and Mombereau, 2004; Cryan…”
BackgroundResultBourin, M., & Hascoët, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01274-3 · Cited by 1,440 · cited 2× · see citing works
“…for changes in anxiety-like behavior in the elevated plus maze (Pellow et al., 1985; Lister, 1987; Rodgers and Dalvi, 1997)and the light/dark box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980) and depressionlike behavior in the forced swim test (Lucki, 1997; Petit-Demouliere et al., 2005;…”
BackgroundPreliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J. N., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,432 · cited 2× · see citing works
“…behavior in the elevated plus maze (Pellow et al., 1985; Lister, 1987; Rodgers and Dalvi, 1997)and the light/dark box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980) and depressionlike behavior in the forced swim test (Lucki, 1997; Petit-Demouliere et al., 2005; Porsolt et al., 1977) and…”
BackgroundMethodHall, C. S. (1934) · Journal of comparative psychology · doi:10.1037/h0071444 · Cited by 1,365 · cited 1× · see citing works
“In addition, basal and novelty-induced locomotor activity were examined by home-cage activity and in the open field test (Hall, 1934; Prut and Belzung, 2003), respectively.”
MethodSchwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289 · cited 1× · see citing works
“In brief, chimeric conditional-KO floxed mice (Y2lox/lox or Y4lox/lox) were crossed with oocyte-specific Cre-recombinase expressing C57BL/6 mice (Schwenk et al., 1995).”
MethodThe ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198 · cited 1× · see citing works
“In contrast to other paradigms, this test is not based on increased exploration as an index of anxiolytic-like effects (Cryan and Holmes, 2005).”
ResultAnxiety, defence and the elevated plus-maze.
Rodgers, R., & Dalvi, A. (1997) · Neuroscience and Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00058-9 · Cited by 1,028 · cited 1× · see citing works
“…our present study we investigated male Y4 KO mice for changes in anxiety-like behavior in the elevated plus maze (Pellow et al., 1985; Lister, 1987; Rodgers and Dalvi, 1997)and the light/dark box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980) and depressionlike behavior in the forced swim…”
BackgroundForced swimming test in mice: A review of antidepressant activity
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2048-7 · Cited by 1,003 · cited 3× · see citing works
“, 1985; Lister, 1987; Rodgers and Dalvi, 1997)and the light/dark box (Bourin and Hascoet, 2003; Crawley and Goodwin, 1980) and depressionlike behavior in the forced swim test (Lucki, 1997; Petit-Demouliere et al., 2005; Porsolt et al., 1977) and tail suspension test (Cryan et al.”
BackgroundMethodMichel, M. C., Beck‐Sickinger, A. G., Cox, H. M., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. W., & Westfall, T. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01352-8 · Cited by 896 · cited 1× · see citing works
“Several Gi/o coupled receptors (Y1, Y2, Y4, Y5, y6) (Michel et al., 1998) are mediating actions of these peptides.”
BackgroundLucki, I. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00010 · Cited by 803 · cited 4× · see citing works
“In contrast to the traditional forced swim test, the tail suspension test detects the efficacy of a broad spectrum of antidepressant treatments (Cryan et al., 2002; Lucki, 1997), including selective 5-HT reuptake inhibitors and it is independent of swimming ability or thermoregulation (Cryan and Mombereau, 2004; Cryan…”
BackgroundResultInfluentialThe NPY system in stress, anxiety and depression
Heilig, M. A. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 617 · cited 1× · see citing works
“NPY is thought to act primarily through Y1, Y2 and Y5 receptors to which it binds at affinities of 20–100 pM and exerts its prominent effects on anxiety and stress-coping behavior in rats and mice (Heilig, 2004).”
BackgroundCryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616 · cited 2× · see citing works
“These tests have been pharmacologically validated to be sensitive to treatment with antidepressant drugs as well as for phenotypic changes in transgenic mice (Cryan et al., 2002; Cryan and Mombereau, 2004).”
BackgroundXu, Y.-L., Reinscheid, R. K., Huitrón‐Reséndiz, S., Clark, S. D., Wang, Z., Lin, S. H., Brücher, F., Zeng, J., Ly, N. K., Henriksen, S. J., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.005 · Cited by 510 · cited 4× · see citing works
“…Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even inversely dependent on motor activity, respectively.”
BackgroundMethodInfluentialEvaluation of marble-burying behavior as a model of anxiety
Njung'e, K., & Handley, S. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90590-x · Cited by 487 · cited 3× · see citing works
“…Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even inversely dependent on motor activity, respectively.”
BackgroundMethodRegional distribution of Y‐receptor subtype mRNAs in rat brain
Parker, R. M. C., & Herzog, H. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00553.x · Cited by 412 · cited 3× · see citing works
“E urope PM C Funders A uthor M anuscripts E urope PM C Funders A uthor M anuscripts Parker and Herzog, 1999).”
BackgroundAdrenergic activation of triiodothyronine production in brown adipose tissue
Silva, J. E., & Larsen, P. R. (1983) · Nature · doi:10.1038/305712a0 · Cited by 401 · cited 1× · see citing works
“Together with altered sympathetic signaling, increased thyrotropin releasing hormone mRNA levels in the paraventricular nucleus of the hypothalamus could be a cause for changes in thermoregulation in Y2/Y4 KO mice (Ribeiro et al., 2001; Sainsbury et al., 2003, 2006; Silva and Larsen, 1983).”
BackgroundEvolution of neuropeptide Y, peptide YY and pancreatic polypeptide
Larhammar, D. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(95)00169-7 · Cited by 388 · cited 1× · see citing works
“Like neuropeptide Y (NPY) and peptide YY (PYY) it belongs to the so-called PP-fold peptide family (Berglund et al., 2003; Larhammar, 1996).”
BackgroundBard, J., Walker, M. W., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26762 · Cited by 377 · cited 3× · see citing works
“. uthor M anuscripts E urope PM C Funders A uthor M anuscripts Whereas high Y4 mRNA concentrations are present in the peripheral tissues, they are considerably lower in the brain (Bard et al., 1995; Lundell et al., 1997).”
BackgroundThe neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358 · cited 4× · see citing works
“Local injections of NPY agonists (Kask et al., 2002) and site-specific deletion of Y2 receptors in amygdaloid nuclei performed by our group demonstrated an important role of the amygdala in Y1 and Y2 receptor-mediated mechanisms of NPY on emotional behavior (Tasan et al., 2007).”
BackgroundInfluentialHeilig, M. A., McLeod, S., Brot, M. D., Heinrichs, S. C., Menzaghi, F., Koob, G. F., & Britton, K. T. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.35 · Cited by 356 · cited 2× · see citing works
“Pressure injection of NPY and of Y1 receptor agonists, produced pronounced anxiolytic and antidepressant-like effects, notably in the amygdaloid nuclei (Heilig et al., 1993; Kask et al., 2002; Redrobe et al., 2002), whereas injection of Y2 receptor agonists into the basolateral amygdala was anxiogenic (Sajdyk et al.”
BackgroundCharacterization of the effects of pancreatic polypeptide in the regulation of energy balance
Asakawa, A., Inui, A., Yuzuriha, H., Ueno, N., Katsuura, G., Fujimiya, M., Fujino, M., Niijima, A., Meguid, M. M., & Kasuga, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00216-6 · Cited by 350 · cited 3× · see citing works
“In contrast, repeated i.p. injection of mouse PP in fatty lizer Shoinogy ob/ob obese mice resulted in an anxiolytic effect (Asakawa et al., 2003).”
BackgroundDo animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347 · cited 4× · see citing works
“…hyperthermia (Borsini et al., 1989; Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even…”
BackgroundInfluentialBroekkamp, C. L., Rijk, H. W., Joly-Gelouin, D., & Lloyd, K. L. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90051-8 · Cited by 286 · cited 2× · see citing works
“, 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even inversely dependent on motor activity, respectively.”
BackgroundRibeiro, M. O., Carvalho, S. D., Schultz, J. J., Chiellini, G., Scanlan, T. S., Bianco, A. C., & Brent, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112584 · Cited by 271 · cited 1× · see citing works
“Together with altered sympathetic signaling, increased thyrotropin releasing hormone mRNA levels in the paraventricular nucleus of the hypothalamus could be a cause for changes in thermoregulation in Y2/Y4 KO mice (Ribeiro et al., 2001; Sainsbury et al., 2003, 2006; Silva and Larsen, 1983).”
BackgroundBerglund, M. M., Hipskind, P. A., & Gehlert, D. R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800301 · Cited by 260 · cited 3× · see citing works
“Like neuropeptide Y (NPY) and peptide YY (PYY) it belongs to the so-called PP-fold peptide family (Berglund et al., 2003; Larhammar, 1996).”
BackgroundSainsbury, A., Schwarzer, C., Couzens, M., Fetissov, S. O., Fürtinger, S., Jenkins, A. B., Cox, H. M., Sperk, G., Hökfelt, T. G. M., & Herzog, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132043299 · Cited by 244 · cited 5× · see citing works
“Thus, Y4 receptor knockout (KO) mice revealed signs of reduced weight gain, altered expression of gonadotropin-releasing hormone as well as increased male aggressive behavior (Asakawa et al., 2003; Sainsbury et al., 2002b, 2003).”
BackgroundMethodResultInfluentialNicolas, L. B., Kolb, Y., & Prinssen, E. P. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.015 · Cited by 234 · cited 2× · see citing works
“…Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even inversely dependent on motor activity, respectively.”
BackgroundEbner, K., Rupniak, N. M. J., Saria, A., & Singewald, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400794101 · Cited by 225 · cited 1× · see citing works
“…e.g. in the area postrema or in the lateral hypothalamus upon Y4 receptors) may indirectly result in an activation of the medial amygdala and other nuclei related to integration of emotions, linking induction of satiety with potential changes in anxiety-related behavior (Ebner et al., 2004).”
BackgroundStress-induced hyperthermia and anxiety: pharmacological validation
Olivier, B., Zethof, T. J. J., Pattij, T., van Bogaert, M. J. V., van Oorschot, R., Leahy, C. L., Oosting, R. S., Bouwknecht, J. A., Veening, J. G., van der Gugten, J., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01326-8 · Cited by 209 · cited 3× · see citing works
“…from changes in novelty-induced locomotor activity, we additionally used stress-induced hyperthermia (Borsini et al., 1989; Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006;…”
BackgroundMethodRedrobe, J. P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00403-1 · Cited by 207 · cited 2× · see citing works
“Pressure injection of NPY and of Y1 receptor agonists, produced pronounced anxiolytic and antidepressant-like effects, notably in the amygdaloid nuclei (Heilig et al., 1993; Kask et al., 2002; Redrobe et al., 2002), whereas injection of Y2 receptor agonists into the basolateral amygdala was anxiogenic (Sajdyk et al.”
BackgroundGreber, S., Schwarzer, C., & Sperk, G. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17055.x · Cited by 203 · cited 2× · see citing works
“Y1 receptors mediate their action including anxiolysis primarily at postsynaptic sites, whereas Y2 receptors are mostly located presynaptically on NPY/GABA neurons or at terminals of glutaminergic axons (Parker and Balasubramaniam, 2008), where they inhibit the release of classical transmitters (Adewale et al., 2005;…”
BackgroundStress-Induced Hyperthermia in Singly Housed Mice
Heyden, J. V. D. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00157-1 · Cited by 194 · cited 2× · see citing works
“After an adaptation period of 90 min basal temperature was obtained with a rectal mouse probe (Van der Heyden et al., 1997).”
MethodReduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors
Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H., & Sperk, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02725.x · Cited by 180 · cited 2× · see citing works
“We and others demonstrated that deletion of Y2 receptors results in pronounced anxiolytic and antidepressant-like effects (Carvajal et al., 2006; Redrobe et al., 2003; Tschenett et al., 2003).”
BackgroundMethodY4 receptor knockout rescues fertility in ob/ob micePreprint
Sainsbury, A., Schwarzer, C., Couzens, M., Jenkins, A. B., Oakes, S. R., Ormandy, C. J., & Herzog, H. (2002) · Genes & Development · doi:10.1101/gad.979102 · Cited by 170 · see citing works
A model to measure anticipatory anxiety in mice?
Borsini, F., Lecci, A., Volterra, G., & Meli, A. (1989) · Psychopharmacology · doi:10.1007/bf00444693 · Cited by 153 · cited 2× · see citing works
“For differentiating anxiolytic-like behavior from changes in novelty-induced locomotor activity, we additionally used stress-induced hyperthermia (Borsini et al., 1989; Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002;…”
MethodLimitations on the use of the C57BL/6 mouse in the tail suspension test
Mayorga, A. J., & Lucki, I. (2001) · Psychopharmacology · doi:10.1007/s002130100687 · Cited by 147 · see citing works
Plasticity of Y1 and Y2 Receptors and Neuropeptide Y Fibers in Patients with Temporal Lobe Epilepsy
Fürtinger, S., Pirker, S., Czech, T., Baumgartner, C., Ransmayr, G. N., & Sperk, G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05804.2001 · Cited by 145 · cited 2× · see citing works
“Assays were performed as described previously (Furtinger et al., 2001).”
MethodNeuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry
Singewald, N., & Sharp, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00177-9 · Cited by 145 · cited 1× · see citing works
“Although the exact relation of the nucleus tractus solitarius with anxiety is not established, it is interesting to note that different anxiogenic drugs can activate c-Fos expression in this brain area (Singewald and Sharp, 2000).”
BackgroundSaha, S., Batten, T. F. C., & Henderson, Z. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00240-2 · Cited by 135 · cited 1× · see citing works
“There exists also an interplay between the nucleus tractus solitarius containing high concentrations of Y4 receptors with the central nucleus of the amygdala, since it receives a dense GABA-ergic input from this brain area (Saha et al., 2000).”
BackgroundCharacterization of saturable binding sites for circulating pancreatic polypeptide in rat brain
Whitcomb, D. C., Taylor, I. L., & Vigna, S. R. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.259.4.g687 · Cited by 133 · cited 3× · see citing works
“On the other hand, in vivo, peripheral PP is able to access PP-binding receptors in the area postrema, which circumvents the blood–brain barrier (Whitcomb et al., 1990), and a central action of PP has been established after local injection (McTigue and Rogers, 1995).”
BackgroundPancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y
DiMaggio, D. A., Chronwall, B. M., Buchanan, K. D., & O'Donohoue, T. L. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90259-3 · Cited by 131 · cited 1× · see citing works
“Nevertheless affinities of NPY and PYY (kB=1 nM) are still in a physiological/ pharmacological range and affinities of PP-fold peptides to Y4 receptors may be different in brain tissue (DiMaggio et al., 1985).”
BackgroundRedrobe, J. P., Dumont, Y., Herzog, H., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00374-1 · Cited by 131 · cited 1× · see citing works
“We and others demonstrated that deletion of Y2 receptors results in pronounced anxiolytic and antidepressant-like effects (Carvajal et al., 2006; Redrobe et al., 2003; Tschenett et al., 2003).”
BackgroundAcuna, C., Tamamaki, N., Yanagawa, Y., Obata, K., & van den Pol, A. N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1008-05.2005 · Cited by 127 · cited 2× · see citing works
“…and the similar signaling pathways used by Y2 and Y4 receptors it may be possible that Y4 receptors, either activated by NPY or by PP, are located presynaptically on terminals in brain stem or hypothalamic nuclei, resulting in an inhibition of transmitter release (Acuna-Goycolea et al., 2005).”
BackgroundNeuropeptide Y-Y2 receptors mediate anxiety in the amygdala
Sajdyk, T. J., Schober, D. A., Smiley, D. L., & Gehlert, D. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00679-7 · Cited by 123 · cited 2× · see citing works
“, 2002), whereas injection of Y2 receptor agonists into the basolateral amygdala was anxiogenic (Sajdyk et al., 2002).”
BackgroundPharmacological validation of a novel animal model of anticipatory anxiety in mice
Lecci, A., Borsini, F., Volterra, G., & Meli, A. (1990) · Psychopharmacology · doi:10.1007/bf02244136 · Cited by 118 · cited 2× · see citing works
“For differentiating anxiolytic-like behavior from changes in novelty-induced locomotor activity, we additionally used stress-induced hyperthermia (Borsini et al., 1989; Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al.”
MethodMouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice☆
Asakawa, A., Inui, A., Ueno, N., Fujimiya, M., Fujino, M., & Kasuga, M. (1999) · Peptides · doi:10.1016/s0196-9781(99)00155-2 · Cited by 112 · cited 2× · see citing works
“An earlier study reported no difference regarding anxiety behavior after single injections of mPP into the ventricles (Asakawa et al., 1999).”
BackgroundDistribution of NPY receptors in the hypothalamus
Fetissov, S. O., Kopp, J., & Hökfelt, T. G. M. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.009 · Cited by 110 · cited 1× · see citing works
“In the rat, Y4 receptors are primarily concentrated in the hypothalamus and in the brain stem (Fetissov et al., 2004; Lundell et al., 1997; Whitcomb et al., 1997).”
BackgroundSainsbury, A., Baldock, P. A. J., Schwarzer, C., Ueno, N., Enriquez, R. F., Couzens, M., Inui, A., Herzog, H., & Gardiner, E. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5225-5233.2003 · Cited by 109 · cited 3× · see citing works
“Together with altered sympathetic signaling, increased thyrotropin releasing hormone mRNA levels in the paraventricular nucleus of the hypothalamus could be a cause for changes in thermoregulation in Y2/Y4 KO mice (Ribeiro et al., 2001; Sainsbury et al., 2003, 2006; Silva and Larsen, 1983).”
BackgroundNeuropeptide Y Y2 receptor in health and disease
Parker, S. L., & Balasubramaniam, A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707445 · Cited by 84 · cited 2× · see citing works
“…primarily at postsynaptic sites, whereas Y2 receptors are mostly located presynaptically on NPY/GABA neurons or at terminals of glutaminergic axons (Parker and Balasubramaniam, 2008), where they inhibit the release of classical transmitters (Adewale et al., 2005; Chen et al., 1997; Greber et al.,…”
BackgroundGehlert, D. R., Schober, D. A., Beavers, L. S., Gadski, R. A., Hoffman, J. A., Smiley, D. L., Chance, R. E., Lundell, I., & Larhammar, D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09120-5 · Cited by 82 · cited 2× · see citing works
“Studies in cell lines expressing recombinant Y4 receptors indicate that PP may be the primary PP-fold peptide acting on Y4 receptors (Berglund et al., 2001; Gehlert et al., 1996).”
BackgroundReduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice
Painsipp, E., Wultsch, T., Edelsbrunner, M. E., Tasan, R. O., Singewald, N., Herzog, H., & Holzer, P. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00389.x · Cited by 79 · cited 2× · see citing works
“Recently Painsipp et al. (2008) demonstrated an anxiolytic and anti-depressant-like effect of Y4 receptor deletion in female mice.”
BackgroundResultCloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
Yan, H., Yang, J., Marasco, J., Yamaguchi, K., Brenner, S., Collins, F., & Karbon, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4661 · Cited by 79 · cited 1× · see citing works
“PP is there about 100 times more potent than NPY or PYY in inhibiting binding of [125I]Leu31Pro34PYY and [125I]PP to Y4 binding sites (Yan et al., 1996; Gehlert et al., 1997).”
BackgroundChen, X., DiMaggio, D. A., Han, S. P., & Westfall, T. C. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.4.h1737 · Cited by 77 · cited 2× · see citing works
“Y1 receptors mediate their action including anxiolysis primarily at postsynaptic sites, whereas Y2 receptors are mostly located presynaptically on NPY/GABA neurons or at terminals of glutaminergic axons (Parker and Balasubramaniam, 2008), where they inhibit the release of classical transmitters (Adewale et al., 2005;…”
BackgroundDistribution of pancreatic polypeptide receptors in the rat brain
Whitcomb, D. C., Puccio, A. M., Vigna, S. R., Taylor, I. L., & Hoffman, G. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00295-3 · Cited by 70 · cited 1× · see citing works
“In the rat, Y4 receptors are primarily concentrated in the hypothalamus and in the brain stem (Fetissov et al., 2004; Lundell et al., 1997; Whitcomb et al., 1997).”
BackgroundGehlert, D. R., Schober, D. A., Gackenheimer, S. L., Beavers, L. S., Gadski, R. A., Lundell, I., & Larhammar, D. (1997) · Peptides · doi:10.1016/s0196-9781(96)00346-4 · Cited by 64 · cited 1× · see citing works
“PP is there about 100 times more potent than NPY or PYY in inhibiting binding of [125I]Leu31Pro34PYY and [125I]PP to Y4 binding sites (Yan et al., 1996; Gehlert et al., 1997).”
BackgroundCloning and Characterization of a Novel Neuropeptide Y Receptor Subtype in the Zebrafish
Lundell, I., BERGLUND, M. M., Starbäck, P., Salaneck, E., Gehlert, D. R., & Larhammar, D. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1357 · Cited by 60 · cited 3× · see citing works
“. uthor M anuscripts E urope PM C Funders A uthor M anuscripts Whereas high Y4 mRNA concentrations are present in the peripheral tissues, they are considerably lower in the brain (Bard et al., 1995; Lundell et al., 1997).”
BackgroundAbounader, R., Elhusseiny, A., Cohen, Z., Olivier, A., Stanimirovic, D. B., Quirion, R., & Hamel, É. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199902000-00007 · Cited by 57 · cited 1× · see citing works
“Interestingly, Y4 receptors have been also found in human astrocyte cultures, indicating a possible role of glial cells in Y4 receptor actions (Abounader et al., 1999).”
BackgroundSainsbury, A., Bergen, H., Boey, D., Bamming, D., Cooney, G. J., Lin, S., Couzens, M., Stroth, N., Lee, N. J., Lindner, D., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0472 · Cited by 47 · cited 2× · see citing works
“Together with altered sympathetic signaling, increased thyrotropin releasing hormone mRNA levels in the paraventricular nucleus of the hypothalamus could be a cause for changes in thermoregulation in Y2/Y4 KO mice (Ribeiro et al., 2001; Sainsbury et al., 2003, 2006; Silva and Larsen, 1983).”
BackgroundDumont, Y., Moyse, E., Fournier, A., & Quirion, R. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9007-9 · Cited by 42 · cited 1× · see citing works
“Radiolabeled PP accumulates presumably at the high abundant Y4 receptors in the area postrema (Dumont et al., 2007).”
BackgroundVoisin, T., Goumain, M., Lorinet, A.-M., Maoret, J.-J., & Laburthe, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35334-0 · Cited by 41 · cited 1× · see citing works
“Both, Y2 and Y4 receptors predominantly interact with Gi and Gq resulting in inhibition of cAMP accumulation (Freitag et al., 1995; Voisin et al., 2000; Walker et al., 1997).”
BackgroundEmotional Behavior in Aged Neuropeptide Y (NPY) Y2 Knockout Mice
Carvajal, C., Dumont, Y., Herzog, H., & Quirion, R. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:3:239 · Cited by 39 · cited 1× · see citing works
“We and others demonstrated that deletion of Y2 receptors results in pronounced anxiolytic and antidepressant-like effects (Carvajal et al., 2006; Redrobe et al., 2003; Tschenett et al., 2003).”
BackgroundA Structure-Activity Analysis of the Cloned Rat and Human Y4 Receptors for Pancreatic Polypeptide
Walker, M. W., Smith, K. E., Bard, J., Vaysse, P. J. ‐., Gerald, C., Daouti, S., Weinshank, R. L., & Branchek, T. A. (1997) · Peptides · doi:10.1016/s0196-9781(97)00070-3 · Cited by 35 · cited 1× · see citing works
“Both, Y2 and Y4 receptors predominantly interact with Gi and Gq resulting in inhibition of cAMP accumulation (Freitag et al., 1995; Voisin et al., 2000; Walker et al., 1997).”
BackgroundTrinh, T., Dumont, Y., & Quirion, R. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00863-1 · Cited by 35 · cited 1× · see citing works
“Also Y4 mRNA was observed in these areas of the rat indicating that the receptors may be expressed in local neurons (Whitcomb et al., 1990; Trinh et al., 1996; Parker and Herzog, 1999).”
BackgroundNeuropeptide Y induced modulation of dopamine synthesis in the striatum
Adewale, A. S., Macarthur, H., & Westfall, T. C. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.01.005 · Cited by 29 · cited 2× · see citing works
“Y1 receptors mediate their action including anxiolysis primarily at postsynaptic sites, whereas Y2 receptors are mostly located presynaptically on NPY/GABA neurons or at terminals of glutaminergic axons (Parker and Balasubramaniam, 2008), where they inhibit the release of classical transmitters (Adewale et al., 2005;…”
BackgroundArea postrema lesions elevate NPY levels and decrease anxiety-related behavior in rats
Miller, C. C., Holmes, P. V., & Edwards, G. L. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00847-8 · Cited by 26 · cited 1× · see citing works
“Interestingly, lesions of the area postrema, containing high concentrations of Y4 receptors, result in increased NPY expression in the amygdala and reduced anxiety (Miller et al., 2002).”
BackgroundBerglund, M. M., Lundell, I., Eriksson, H., Söll, R., Beck‐Sickinger, A. G., & Larhammar, D. (2001) · Peptides · doi:10.1016/s0196-9781(01)00337-0 · Cited by 25 · cited 2× · see citing works
“Studies in cell lines expressing recombinant Y4 receptors indicate that PP may be the primary PP-fold peptide acting on Y4 receptors (Berglund et al., 2001; Gehlert et al., 1996).”
BackgroundFreitag, C., Svendsen, A. B., Feldthus, N., Løssl, K., & Sheikh, S. P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020643.x · Cited by 24 · see citing works
Characterization of neuropeptide Y Y1-like and Y2-like receptor subtypes in the mouse brain
Gackenheimer, S. L., Schober, D. A., & Gehlert, D. R. (2001) · Peptides · doi:10.1016/s0196-9781(01)00335-7 · Cited by 21 · cited 1× · see citing works
“…of Y2 and Y4 receptors In situ hybridization and receptor autoradiography revealed high levels of Y2 receptor mRNA and binding sites in various limbic brain areas, notably in the amygdala and the hippocampus, as previously described (Dumont et al., 1998; Gackenheimer et al., 2001; Neuroscience.”
MethodPancreatic polypeptide stimulates gastric acid secretion through a vagal mechanism in rats
McTigue, D. M., & Rogers, R. C. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.5.r983 · Cited by 19 · cited 2× · see citing works
“In spite of its apparently relatively low affinity to Y4 receptors, NPY appears to be the only reasonable candidate as a ligand for central Y4 receptors and NPY can still activate Y4 receptors at nanomolar concentration (Bard et al., 1995; McTigue and Rogers, 1995).”
BackgroundUeno, N., Asakawa, A., Satoh, Y., & Inui, A. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.019 · Cited by 16 · cited 2× · see citing works
“This is supported by a recent report suggesting an anxiogenic phenotype in PP over-expressing mice (Ueno et al., 2007).”
ResultSchwarzer, C., Kirchmair, E., & Sperk, G. (1998) · Neuroreport · doi:10.1097/00001756-199807130-00036 · Cited by 9 · cited 1× · see citing works
“In situ hybridization of Y2 receptor mRNA was done essentially as described previously (Schwarzer et al., 1998).”
MethodTasan, R. O., Weger, S., Heilbronn, R., Nguyen, N. K., Singewald, N., Herzog, H., & Sperk, G. (2007) · BMC Pharmacology · doi:10.1186/1471-2210-7-s2-a14 · Cited by 2 · cited 2× · see citing works
“Local injections of NPY agonists (Kask et al., 2002) and site-specific deletion of Y2 receptors in amygdaloid nuclei performed by our group demonstrated an important role of the amygdala in Y1 and Y2 receptor-mediated mechanisms of NPY on emotional behavior (Tasan et al., 2007).”
BackgroundMatelli (1998) · doi:10.1002/(sici)1096-9861(19981221)402:3
Flagged first, then by citations
Research works printed but not linked: 3
- Dumont Y Jacques D Bouchard P Quirion R Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains J Comp Neurol 1998 402 372 384 9853905
- Gehlert DR Schober DA Gackenheimer SL Beavers L Gadski R Lundell I Larhammar D [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors Peptides 1997 18 397 401 9145427
- Rodgers RJ Dalvi A Anxiety, defence and the elevated plusmaze Neurosci Biobehav Rev 1997 21 801 810 9415905
Cited by
Sorted by citations
Panossian, A. G., Wikman, G., & Sarris, J. J. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.02.002 · Cited by 608 · see citing works
“Other possible mechanisms of action Rhodola extracts are not excluded, such as a possible effect on neuropeptide Y receptors (Larhammar and Salaneck, 2004) and expression of neuropeptide Y which is known play important role in regulation of energy balance, memory and learning, anxiety and depression (Heilig, 2004; Saj…”
BackgroundAnxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573 · see citing works
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501 · see citing works
“The amygdala, which is a key brain region coordinating behavioural stress responses (McEwen, 2007), contains high levels of NPY and Y1, Y2, Y4 and Y5 receptors (Parker and Herzog, 1999; Kask et al., 2002; Kopp et al., 2002; Wolak et al., 2003; Tasan et al., 2009).”
InfluentialNeuropeptide Y: a stressful review
Reichmann, F., & Holzer, P. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.008 · Cited by 490 · see citing works
“The anxiolytic effect of Y4 receptor deletion is amplified by Y2/Y4 receptor double knockout, suggesting a positive interaction of Y2 and Y4 receptors (Tasan et al., 2009).”
BackgroundNeuropeptides and the Microbiota-Gut-Brain Axis
Holzer, P., & Farzi, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_9 · Cited by 451 · see citing works
“The major receptor subtypes which NPY acts on are the Y1 and Y2 receptors, which are widely distributed in the central nervous system, while the localization of Y4 and Y5 receptors is restricted to particular regions of the brain [82-85].”
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 327 · see citing works
“Y4 receptor deficient mice were shown to have reduced anxiety and depression like behavior (Painsipp et al., 2008), and Y2/Y4 double knockout mice showed further decreased depression levels (Tasan et al., 2009).”
Petraglia, A. L., Plog, B. A., Dayawansa, S., Chen, M. J., Dashnaw, M. L., Czerniecka, K. H., Walker, C. T., Viterise, T., Hyrien, O., Iliff, J. J., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3255 · Cited by 219 · see citing works
A possible role of neuropeptide Y in depression and stress
Morales‐Medina, J. C., Dumont, Y., & Quirion, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.077 · Cited by 217 · see citing works
“In addition, Y2/Y4 double KO mice showed augmented reduction in immobility time in the FST, compared to Y2-deficient male mice (Tasan et al., 2009).”
Influentialde Brouwer, G., Fick, A., Harvey, B. H., & Wolmarans, D. W. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-00653-4 · Cited by 188 · see citing works
The Basal Forebrain Cholinergic Projection System in Mice
Záborszky, L., van den Pol, A. N., & Gyengési, E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10028-7 · Cited by 166 · see citing works
“Recently, a number of transgenic mice have been generated to investigate the expression pattern and function of these receptors (Edelsbrunner et al., 2009a, b; Oberto et al., 2007; Painsipp et al., 2008; Tasan et al., 2009).”
BackgroundThe role of NPY in learning and memory
Gøtzsche, C. R., & Woldbye, D. P. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.09.010 · Cited by 162 · see citing works
“…that NPY ligands can influence emotional behaviours (via Y1, Y2, Y4, and Y5; Kask et al., 2002; Redrobe et al., 2002; Sørensen et al., 2004; Tasan et al., 2009, 2010; MoralesMedina et al., 2010), motivational feeding behaviour (Berglund et al., 2003), as well as locomotor activity and…”
Neuropeptide Y Stimulates Food Intake in the Zebrafish, Danio rerio
Yokobori, E., Azuma, M., Nishiguchi, R., Kang, K. S., Kamijo, M., Uchiyama, M., & Matsuda, K. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02281.x · Cited by 156 · see citing works
Tasan, R. O., Nguyen, N. K., Weger, S., Sartori, S. B., Singewald, N., Heilbronn, R., Herzog, H., & Sperk, G. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0430-10.2010 · Cited by 152 · see citing works
“The open field test was performed to measure overall motor activity, and was performed as described previously (Hall, 1934; Tschenett et al., 2003; Tasan et al., 2009).”
MethodFarzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145 · see citing works
“Despite the limited distribution of the Y4 receptor in the brain, KO of this receptor is associated with reduced anxiety- and depression-related behaviours (Painsipp et al. 2008b, Tasan et al. 2009).”
BackgroundNeuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
Duarte‐Neves, J., de Almeida, L. P., & Cavadas, C. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.022 · Cited by 137 · see citing works
“Experiments using Y2 receptors or Y4 receptors knock-out mice revealed that the suppression of these receptors subtypes result in a significant restraint of depression (Carvajal et al., 2006; Painsipp et al., 2008b; Tasan et al., 2009; Tschenett et al., 2003).”
MethodTargeting the neuropeptide Y system in stress-related psychiatric disorders
Enman, N. M., Sabban, E. L., McGonigle, P., & Bockstaele, E. J. V. (2014) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.09.007 · Cited by 126 · see citing works
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Yi, M., Li, H., Wu, Z., Yan, J., Liu, Q., Ou, C., & Chen, M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486225 · Cited by 126 · see citing works
The role of Neuropeptide Y in fear conditioning and extinction
Tasan, R. O., Verma, D., Wood, J. C., Lach, G., Hörmer, B. A., de Lima, T. C. M., Herzog, H., & Sperk, G. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.09.007 · Cited by 117 · see citing works
“In the central nervous system, Y4 receptors are expressed in specific brain areas, such as the hypothalamus and brain stem (Tasan et al., 2009).”
BackgroundGiesbrecht, C. J., Mackay, J. P., Silveira, H., Urban, J. H., & Colmers, W. F. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2306-10.2010 · Cited by 108 · see citing works
“Although behavioral experiments on Y2 receptor knockout mice have reported an anxiolytic phenotype (Tschenett et al., 2003; Tasan et al., 2009, 2010), this appears to result from loss of presynaptic Y2 receptors on fibers originating in the central amygdala.”
Painsipp, E., Herzog, H., Sperk, G., & Holzer, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01326.x · Cited by 93 · see citing works
“The observations in NPY-/- and PYY-/mice are complemented by distinct alterations of anxietyand depression-related behaviour in Y1, Y2 and Y4 knockout mice (Redrobe et al., 2003; Tschenett et al., 2003; Eva et al., 2006; Karl et al., 2006; Painsipp et al., 2008; Tasan et al., 2009).”
BackgroundMeirsman, A. C., Merrer, J. L., Pellissier, L. P., Díaz, J., Clesse, D., Kieffer, B. L., & Becker, J. A. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.020 · Cited by 92 · see citing works
“Decreased marble burying in mutant mice can also be interpreted as a sign of lower anxiety (61) or may result from hyperactivity (38, 62, 63).”
BackgroundNeuropeptide Y, resilience, and PTSD therapeutics
Kautz, M. M., Charney, D. S., & Murrough, J. W. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.061 · Cited by 90 · see citing works
Neuropeptide Y in Alcohol Addiction and Affective Disorders
Thorsell, A., & Mathé, A. A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00178 · Cited by 83 · see citing works
Neuroendocrine control of feeding behavior and psychomotor activity by neuropeptideY in fish
Matsuda, K., Sakashita, A., Yokobori, E., & Azuma, M. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.09.006 · Cited by 72 · see citing works
“On the other hand, it has been demonstrated that the NPY Y2 and Y4 receptors, but not the Y5 receptor, play an important role in the regulation of emotional behavior in mice (Edelsbrunner et al., 2009; Tasan et al., 2009; Olesen et al., 2012).”
BackgroundHunger promotes fear extinction by activation of an amygdala microcircuit
Verma, D., Wood, J., Lach, G., Herzog, H., Sperk, G., & Tasan, R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.163 · Cited by 69 · see citing works
“Interestingly, Y4 receptors are highly expressed in the NTS and peripheral PP injection results in fast activation of NTS neurons (Tasan et al., 2009).”
InfluentialMorales‐Medina, J. C., Dumont, Y., Benoit, C.-É., Bastianetto, S., Flores, G., Fournier, A., & Quirion, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.030 · Cited by 70 · see citing works
NPY controls fear conditioning and fear extinction by combined action on Y1 and Y2 receptors
Verma, D., Tasan, R. O., Herzog, H., & Sperk, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01872.x · Cited by 67 · see citing works
“Activation of presynaptic Y2 receptors increases anxiety-like responses (Nakajima et al., 1998; Sajdyk et al., 2002; Bacchi et al., 2006), whilst deletion of Y2 receptors results in reduced anxiety-like behaviour (Redrobe et al., 2003; Tschenett et al., 2003; Tasan et al., 2009; 2010).”
BackgroundMethodInfluentialBehavioral effect of neuropeptides related to feeding regulation in fish
Matsuda, K., Kang, K. S., Sakashita, A., Yahashi, S., & Vaudry, H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05884.x · Cited by 65 · see citing works
Wood, J. C., Verma, D., Lach, G., Bonaventure, P., Herzog, H., Sperk, G., & Tasan, R. O. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1107-7 · Cited by 62 · see citing works
“C-terminally truncated human peptide YY (hPYY3-36) was radiolabeled with Na125I (2200 Ci/mmol; PerkinElmer, Boston, USA), and brain sections were incubated with the radiolabeled peptide as described in detail previously (Tasan et al. 2009).”
Berlicki, Ł., Kaske, M., Gutiérrez‐Abad, R., Bernhardt, G., Illa, O., Ortuno, R. M., Cabrele, C., Buschauer, A., & Reiser, O. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4008505 · Cited by 56 · see citing works
Chávez-Castillo, M., Núñez, V., Nava, M., Ortega, Á., Rojas, M., Bermúdez, V., & Rojas, J. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/7943481 · Cited by 56 · see citing works
“In contrast, Y2 and Y4 receptor knockout mice have shown more resilient phenotypes in these tests [206, 207], and the infusion of Y2 antagonists—as well as Y1 agonists—has been related with antidepressant effects [202].”
BackgroundSharma, A., Ren, X., Zhang, H., & Pandey, G. N. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110428 · Cited by 52 · see citing works
Edelsbrunner, M., Painsipp, E., Herzog, H., & Holzer, P. D. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.08.007 · Cited by 50 · see citing works
“In addition, the circadian locomotor behaviour of male Y2−/− and Y4−/− mice has been reported by Tasan et al. (2009).”
BackgroundMethodInfluentialAntidepressant-like behavior in brain-specific angiogenesis inhibitor 2-deficient mice
Okajima, D., Kudo, G., & Yokota, H. (2011) · The Journal of Physiological Sciences · doi:10.1007/s12576-010-0120-0 · Cited by 49 · see citing works
“We also assessed basal locomotor activity in the home cage and in the open field test, and spatial learning and memory in the Morris water maze test, respectively [13, 14].”
MethodThe role of pancreatic polypeptide in the regulation of energy homeostasis
Khandekar, N., Berning, B. A., Sainsbury, A., & Lin, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.028 · Cited by 46 · see citing works
Regulation of Neurosteroid Biosynthesis by Neurotransmitters and Neuropeptides
do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Vaudry, D., Luu-The, V., Tonon, M., Tsutsui, K., Pelletier, G., & Vaudry, H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00004 · Cited by 43 · see citing works
“…Y and sulfated neurosteroids are known to regulate the same behavioral activities including response to novelty (von Horsten et al., 1998; Tasan et al., 2009), feeding and satiety (Kalra and Kalra, 2004a,b; Ramos et al., 2005; Beck, 2006; Ueno et al., 2008), and reproductive behavior…”
BackgroundSchizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency
Karl, T., Chesworth, R., Duffy, L., & Herzog, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.029 · Cited by 31 · see citing works
Painsipp, E., Herzog, H., & Holzer, P. D. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348171 · Cited by 31 · see citing works
“The role of Y4 receptors in the control of emotional-affective behaviour (Painsipp et al., 2008b; Tasan et al., 2009) may be related to an appreciable expression of Y4 receptors in amygdala, ventral tegmental area, hippocampus, hypothalamus, locus coeruleus and medullary brainstem (Campbell et al.,…”
BackgroundThe Effects of Ghrelin on Energy Balance and Psychomotor Activity in a Goldfish Model: An Overview
Kang, K. S., Yahashi, S., & Matsuda, K. (2011) · International Journal of Peptides · doi:10.1155/2011/171034 · Cited by 26 · see citing works
der Jeugd, A. V., Vermaercke, B., Halliday, G. M., Staufenbiel, M., & Götz, J. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.007 · Cited by 25 · see citing works
“The light/dark box arena consisted of a Plexiglas box divided by a small underpass into two compartments: a larger brightly lit zone (58 cm long, 28 cm wide, 750 lux) and a smaller covered dark zone (15 cm long, 28 cm wide) (Crawley, 1985; Tasan et al., 2009).”
Domin, H., Szewczyk, B., Pochwat, B., Woźniak, M., & Śmiałowska, M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4495-3 · Cited by 25 · see citing works
“Moreover, the role of Y4R in depression has also been postulated (Painsipp et al. 2008; Tasan et al. 2009).”
BackgroundGender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior
Kreiner, G., Chmielarz, P., Roman, A., & Nalepa, I. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71519-6 · Cited by 22 · see citing works
“[78] [59]”
Neuropeptide receptors as potential pharmacological targets for obesity
Meneguetti, B. T., Cardoso, M. H. E. S., Ribeiro, C. F. A., Felício, M. R., Pinto, I. B., Santos, N. C., Carvalho, C. M. E., & Franco, O. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.002 · Cited by 22 · see citing works
Eva, C. E., Oberto, A., Longo, A., Palanza, P., & Bertocchi, I. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.020 · Cited by 21 · see citing works
Konieczny, A., Braun, D., Wifling, D., Bernhardt, G., & Keller, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00426 · Cited by 19 · see citing works
Verma, D., Hörmer, B. A., Bellmann‐Sickert, K., Thieme, V., Beck‐Sickinger, A. G., Herzog, H., Sperk, G., & Tasan, R. O. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13456 · Cited by 19 · see citing works
“Thus, PP may be considered as a signalling peptide communicating the internal metabolic state to respective CNS centres that generate an adaptive behavioural response.”
BackgroundMethodInfluentialEffects of Laboratory Housing Conditions on Core Temperature and Locomotor Activity in Mice
Russell, L. N., Hyatt, W. S., Gannon, B. M., Simecka, C. M., Randolph, M. M., & Fantegrossi, W. E. (2021) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-20-000093 · Cited by 18 · see citing works
Philips, M., Abramov, U., Lilleväli, K., Luuk, H., Kurrikoff, K., Raud, S., Plaas, M., Innos, J., Puussaar, T., Kõks, S., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.005 · Cited by 17 · see citing works
Clark, T., Hapiak, V., Oakes, M., Mills, H., & Komuniecki, R. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196954 · Cited by 14 · see citing works
Effect of neuropeptide Y on food intake in bullfrog larvae
Shimizu, S., Azuma, M., Morimoto, N., Kikuyama, S., & Matsuda, K. (2013) · Peptides · doi:10.1016/j.peptides.2013.05.014 · Cited by 13 · see citing works
Theisen, C. C., Reyes, B. A. S., Sabban, E. L., & Bockstaele, E. J. V. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.043 · Cited by 11 · see citing works
The Blood-Brain Barrier as a Regulator of the Gut-Brain Axis
Schaeffer, M., Hodson, D. J., & Mollard, P. (2014) · Frontiers of hormone research · doi:10.1159/000358313 · Cited by 13 · see citing works
Neuropeptide Y – Its role in human performance and extreme environments
Kienast, C., Gunga, H., & Steinach, M. (2019) · REACH · doi:10.1016/j.reach.2019.100032 · Cited by 12 · see citing works
Anxiety and the brain: Neuropeptides as emerging factors
Satao, K. S., & Doshi, G. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173878 · Cited by 12 · see citing works
Mood and memory-associated behaviors in neuropeptide Y5 knockout mice
Ito, M., Dumont, Y., & Quirion, R. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.10.009 · Cited by 11 · see citing works
Gleixner, J., Kopanchuk, S., Grätz, L., Tahk, M., Laasfeld, T., Veikšina, S., Höring, C., Gattor, A. O., Humphrys, L. J., Müller, C., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00013 · Cited by 10 · see citing works
Wanka, L., Babilon, S., Burkert, K., Mörl, K., Gurevich, V. V., & Beck‐Sickinger, A. G. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.003 · Cited by 10 · see citing works
“This and additional contribution of the hY4R to anti-secretory effects [3], as well as its possible participation in colon cancer progression [10], and anxiety- and depression-like behaviors [5] suggest this GPCR as a valuable target in several diagnostic and therapeutic approaches.”
BackgroundShieh, K., & Yang, S.-C. (2019) · Journal of Experimental Biology · doi:10.1242/jeb.199356 · Cited by 8 · see citing works
“…Formosanwoodmicewerenot related to long-term inbreeding conditions in the laboratory but might be related to alertness Some animals with genetic mutations, such as neuropeptide Y4 receptor knockout mice, show higher levels of locomotion and less anxiety in the open field test (Tasan et al., 2009).”
BackgroundNinjin'yoeito, a herbal medicine, enhances glucose tolerance in mice
Zhang, L., Gopalasingam, G., & Herzog, H. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102150 · Cited by 6 · see citing works
Differential suppression of hippocampal network oscillations by neuropeptide Y
Pollali, E., & Draguhn, A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110281 · Cited by 3 · see citing works
Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression
Robledo, P., Martín‐García, E., Aso, E., & Maldonado, R. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660741 · Cited by 3 · see citing works
“This anxiolytic and anti depressant-like phenotype was enhanced in Y2/Y4 double knockout mice compared wit h single Y2 and Y4 knockout mice [290] (see Table 3 for summary).”
Feng, Y., 张彩利, Wei, Y., Liu, E., Sun, H., Flatt, P., Gault, V. A., Irwin, N., Hölscher, C., Hao, L., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118074 · Cited by 2 · see citing works
Katsuura, G., & Inui, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801028-0.00165-3 · Cited by 2 · see citing works
Neuropeptide Receptors: Novel Therapeutic Targets for Depression and Anxiety Disorders
Chaki, S., & Kanuma, K. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00300 · Cited by 1 · see citing works
Important role of NPY-Y4R signalling in the dual control of feeding and physical activity
Zhang, L., & Herzog, H. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102425 · Cited by 1 · see citing works
Modulação do influxo de cálcio pelo peptídeo YY (3-36) em células do hipocampo de ratos
Domingues, M. F. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Yoon, S. (2015) · QSpace (Queen's University Library)
Kırmızıbekmez, A. M., Mengi, M., & Yurdakos, E. (2015) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2015.9952
Vakilgilani, T., Zac‐Varghese, S., & Bloom, S. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_3
Inui, A., & Katsuura, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820649-2.00096-6
BindingDB Entry 50010873: Oligopeptides as Neuropeptide Y Y
BindingDB (2021) · UC San Diego · doi:10.7270/q22r3w7v
BindingDB (2014) · UC San Diego · doi:10.7270/q25x2bc9
- Authors
- Tasan, R. O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H., & Sperk, G.
- Affiliations
- Innsbruck Medical University (AT)
- Garvan Institute of Medical Research (AU)
- Universität Innsbruck (AT)
- Corresponding author
- Tasan, R.O.
- Sperk, G.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 158
- Issue
- 4
- Pages
- 1717-1730
- ISSN
- 0306-4522 (ISSN-L)
- PMC
- PMC3034874
- OpenAlex
- W1990350561
- Cited by
- 71
- References
- 80
- Citations by year
- 2026: 1 · 2024: 4 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 11 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neuropeptide Y, Y4 receptor, Y2 receptor, receptor knockout mice, depression-like behavior, anxiety-like behavior, stress-induced hyperthermia, light/dark test, forced swim test, tail suspension test, marble burying test, pancreatic polypeptide, Fos expression, solitary tract nucleus, area postrema, medial amygdala, hypothalamus, satiety signals
- MeSH terms
- Amygdala, Animals, Autoradiography, Depression, Exploratory Behavior, Gene Expression Regulation, Hyperthermia, Induced, Mice, Inbred C57BL, Motor Activity, Pancreatic Polypeptide, Protein Binding, Stress, Psychological, Swimming, Proto-Oncogene Proteins c-fos, Receptors, Neuropeptide Y, Mice, Knockout, Maze Learning, Hindlimb Suspension, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review